Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-08-12CCCC144Mark Mossler plan to sell securities of C4 THERAPEUTICS, INC. under Form 144MEDIUM
Mark Mossler filed Form 144 to notify SEC of plan to sell 19519 units of C4 THERAPEUTICS, INC. securities around 2026-08-12, with aggregate market value of $76,680.39. The total outstanding units is 123025136.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in past 3 mon...
Small CapBiotechnology
2026-08-12BLTE144Hao-Yuan Chuang plan to sell securities of Belite Bio, Inc. under Form 144MEDIUM
Hao-Yuan Chuang filed Form 144 to notify SEC of plan to sell 93800 units of Belite Bio, Inc. securities around 2026-08-12, with aggregate market value of $16,657,004.00. The total outstanding units is 39339960.0. The amount planned to be sold represents 0.24% of total outstanding units; ...
Mid CapBiotechnology